Latest Addiction Medicine News

A recent study has revealed that approximately 1 in 4 teenagers in certain middle and high schools across the United States have reported abusing prescription stimulants intended for attention deficit hyperactivity disorder within the past year

Several organizations say they haven’t heard back from the committee and are confused by OSAC’s methods for distributing the funds.

Fentanyl drives overdose deaths despite harm reduction—expert debate broader implications.

Rather than failing, harm reduction strategies, as articulated by Fiellin and colleagues in the New England Journal of Medicine is generating real benefits to patients and society.

The SEICHE Center for Health and Justice received $1 million from The Tow Foundation and The Connecticut Project to create TC-HUB, a program aimed at building infrastructure and closing gaps to create a more seamless transition for people with chronic health issues leaving the prison system.

The Pain Management Collaboratory Coordinating Center, a Yale-based research center that supports 16 large-scale pragmatic clinical trials of non-drug approaches to managing pain, has been awarded a funding extension to continue its work for six years.

Yale School of Medicine (YSM) second-year MD students and Medical Clinical Experience tutors gathered in YSM’s Donald J. Cohen Auditorium on the evening of November 21, 2024, for a celebration.

Researchers are investigating how the tobacco industry is using social media to promote vaping to teens, and they are developing interventions for deterring e-cigarette use.

Kenneth Morford, MD, assistant professor of medicine (general medicine) at Yale School of Medicine, comments on research suggesting semaglutide can help fight substance use disorder.